Abstract
Abstract The use of methimazole for the treatment of hyperthyroidism in the first trimester of pregnancy has been linked to several congenital malformations. Most commonly reported is choanal atresia; however, other anomalies have been described including aplasia cutis, esophageal atresia, omphalomesenteric duct remnant, and omphalocele. A definitive phenotype of methimazole embryopathy has not been described. We report a case of a newborn with prenatal methimazole exposure who was found to have an H type tracheoesophageal (TE) fistula, vitelline fistula, ruptured omphalocele, as well as multiple duplication cysts of the stomach and small intestine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
